Monday 22nd April 2024

Program

08:00 – 09:15

Breakfast and morning walk along the Pesaro seafront, optional

09:15 – 10:00

Plenary Session 4
The Joint Action JACARDI: a comprehensive action to reduce the burden of diabetes in Europe

Chair: Sarah Wild

Benedetta Armocida (Italy), Department of Cardiovascular, Endocrine-metabolic Diseases and Aging Istituto Superiore di Sanità-ISS, Rome, Italy

More info

Dr. Benedetta Armocida 

Benedetta is a Public Health professional working as a Senior Researcher at the Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, of the Italian National Institute of Health (ISS). With a medical doctor background and a Masters in Tropical Medicine and Global Health, she is currently pursuing a Ph.D. in Global Health at the University of Geneva. Her specific research interests encompass NCDs prevention and management, adolescent health, migrants' health, health policy, and system strengthening.

Benedetta is the Coordinator of the EU4Health Joint Action on Prevention of NCDs – cardiovascular diseases and diabetes – JACARDI. 

Alongside her responsibilities at ISS, she actively contributes to various groups, including the Italian Global Burden of Disease Initiative, the Lancet Commission on Gender-Based Violence and Maltreatment of Young People (Italian Case Study), the Lancet Migration European Hub, and the Research Group on Global Noncommunicable Diseases at the University of Geneva. She also serves as a Lecturer in Global Health and Global NCDs.

Driven by the principle of leaving no one behind, Benedetta is firmly motivated to improve the global health agenda. She dedicates herself to advocating for better health for everyone, everywhere.

 

For more information: Benedetta Armocida

Roberta Papa (Italy), Regional Health Agency Marche Region, Ancona

More info

Roberta Papa

Roberta Papa is an experienced Project Manager and Social Scientist with 20 years of expertise in developing and managing EU-funded projects on health topics. From 2004 to 2017, she worked at IRCCS-INRCA (National Institute of health and science on ageing), specializing in ICT for older people, multimorbidity, active ageing, and psychosocial aspects of ageing. Since 2018, she is seconded at the Regional Health Agency of Marche Region, Italy, overseeing research and internationalization activities on health. She is responsible for EU-funded projects in public health, focusing on health literacy, integrated care, health data, ICT, and frailty. She is the regional representative of the Italian ProMIS network, funded by the Ministry of Health to promote the internationalization of the healthcare systems. She holds a Bachelor's degree in Statistics and a Master's degree in Sociology and Social Research, having co-authored 46 publications.

For more information: Roberta Papa

10:00 – 11:00

Poster Pitches & Boards, session 3
Socioeconomic status, Environmental and Lifestyle

Chair: Anna-Maria Lampousi

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

PP&B17

IMPACT OF SOCIOECONOMIC INEQUALITIES ON COVID-19 MORTALITY OF PEOPLE LIVING WITH DIABETES DURING THE 2020 EPIDEMIC WAVES IN FRANCE

Marie Guion, Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France; Nutritional Epidemiology Research Team (EREN), Sorbonne Paris Nord University, Epidemiology and Statistics Research Centre, University of Paris Cité (CRESS), Bobigny, France

PP&B18

SOCIOECONOMIC STATUS IS AN INCREASINGLY IMPORTANT FACTOR FOR MORTALITY, IN PARTICULAR AMONG MALES WITH DIABETES – A COHORT STUDY FROM THE NETHERLANDS

Jonne Braake, Health Campus The Hague/Department of Public Health and Primary Care, Leiden University Medical Centre, The Hague, The Netherlands

PP&B19

MULTIMORBIDITY ACROSS SOCIOECONOMIC STRATA AND THE ROLE OF LIFESTYLE CHOICES IN THE UK BIOBANK COHORT

Jie Zhang, Department of Public Health, Aarhus University, Aarhus, Denmark

PP&B20

WEATHER PATTERNS IN GREENLAND AND METABOLIC MARKERS

Stine Byberg, Department of Clinical Epidemiology, Steno Diabetes Center Copenhagen, Herlev, Denmark; Steno Diabetes Center Greenland, Nuuk, Greenland

PP&B21

THE ASSOCIATION BETWEEN LIGHT POLLUTION, NOISE AND OUTSIDE TEMPERATURE WITH TYPE 2 DIABETES RISK IN THE GENERAL POPULATION AND THE POTENTIAL MEDIATION BY SLEEP DURATION AND BODY MASS INDEX

Noreen Siddiqui, Amsterdam UMC, location Vrije Universiteit Amsterdam, Epidemiology and Data Science; Amsterdam Public Health, Health Behaviors and Chronic Diseases, Amsterdam, The Netherlands

PP&B22

THE ASSOCIATION OF THE EAT-LANCET DIET SCORE WITH BODY MASS INDEX AND TYPE 2 DIABETES: THE MULTIETHNIC COHORT

Gertraud Maskarinec, University of Hawaii Cancer Center, Honolulu, HI, USA

PP&B23

ASSOCIATION OF A LIFESTYLE INDEX WITH SCORES OF PATIENT-REPORTED OUTCOMES AMONG INDIVIDUALS WITH RECENT-ONSET TYPE 1 AND TYPE 2 DIABETES – A CROSS-SECTIONAL STUDY

Alexander Lang, Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany

PP&B24

THE EFFECT OF ALTERED SLEEP TIMING ON GLYCAEMIC OUTCOMES: SYSTEMATIC REVIEW OF HUMAN INTERVENTION STUDIES

Romy Slebe, Amsterdam UMC; Amsterdam Public Health, Health Behaviors & Chronic Diseases, Amsterdam, The Netherlands

PP&B25

HEALTH LITERACY AND THE ASSOCIATION WITH HEALTH INDICATORS AMONG PEOPLE WITH AND WITHOUT TYPE 2-DIABETES: A POPULATION-BASED STUDY

Anette Andersen, Steno Diabetes Center Aarhus, Aarhus, Denmark

11:00 – 11:30

Exercise & tea/coffee break

11:30 – 12:30

Oral Presentation, session 5
Diabetes & Socioeconomic status

Chair: Edlira Skrami and Morton Jedidiah

10 min. presentations + 5 min. discussion

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

OP17

INCIDENCE OF TYPE 2 DIABETES BY SOCIOECONOMIC DEPRIVATION IN GERMANY BETWEEN 2014 AND 2019

Katharina Piedboeuf, Institute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at the Heinrich Heine University, Düsseldorf, Germany

OP18

THE IMPACT OF SOCIOECONOMIC STATUS ON MORTALITY TRENDS OVER A 16-YEAR PERIOD AMONG PEOPLE WITH DIABETES IN DENMARK

Eeva-Liisa Røssel, Steno Diabetes Center Aarhus; Department of Public Health, Aarhus University, Aarhus, Denmark

OP19

MIGRATION BACKGROUND AND HBA1C CHECKS AND BALANCES: A LARGE ROUTINE CARE DATA STUDY IN THE NETHERLANDS

Marieke Blom, Departments of General Practice; Amsterdam Public Health research Institute, Amsterdam, the Netherlands

OP20

ETHNIC DIFFERENCES IN QUALITY OF DIABETES CARE IN SCOTLAND: A NATIONAL COHORT STUDY

Caroline Jackson, Usher Institute, University of Edinburgh, Edinburgh, UK; On behalf of the Scottish Diabetes Research Network epidemiology group

12:30 – 13:30

Lunch

13:30 – 14:30

Poster Pitches & Boards, session 4
Diabetes Management

Chair: Romain Meer

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

PP&B26

COMPARISON OF GLYCEMIC MARKERS BETWEEN WEEKDAYS AND WEEKEND IN PATIENTS WITH TYPE 1 DIABETES USING CONTINUOUS GLUCOSE MONITORING

Stavros Liatis, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens Medical School, General Hospital of Athens “LAIKO”, Athens, Greece

PP&B27

COMPARISON OF GLUCOSE MANAGEMENT INDICATOR WITH HbA1c VALUE IN PATIENTS WITH TYPE 1 DIABETES USING CONTINUOUS GLUCOSE MONITORING

Eleftheria Papachristoforou, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens Medical School, General Hospital of Athens “LAIKO”, Athens, Greece

PP&B28

AFTER TWO YEARS OF DIABETES ONSET GLYCEMIC CONTROL IMPROVED WITH AID TECHNOLOGY USED AT DIABETES ONSET

Sara Santarelli, Salesi Hospital, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona Umberto I G. M. Lancisi G. Salesi, Department of Women's and Children's Health, Ancona, Italy

PP&B29

PATTERNS OF FOOD INSECURITY OVER TIME RELATED TO ABILITY TO OBTAIN MEDICATION, DIABETES TECHNOLOGY, ACUTE COMPLICATIONS, HEALTH CARE UTILIZATION AND GLYCATED HEMOGLOBIN IN YOUNG ADULTS WITH TYPE 1 DIABETES: THE SEARCH FOOD SECURITY COHORT STUDY

Angela Liese, University of South Carolina, Columbia, South Carolina

PP&B30

ETHNIC DIFFERENCES IN CONTINUOUS GLUCOSE MONITORING-BASED 60-MIN GLUCOSE PREDICTIONS AMONG TYPE 1 DIABETES PATIENTS

Helene Bei Thomsen, Aarhus University, Department of Public Health; Steno Diabetes Center Aarhus, Aarhus, Denmark

PP&B31

MANAGEMENT OF TYPE 2 DIABETES IN NEW ZEALAND: A SCOPING REVIEW OF INTERVENTIONS WITH MEASURABLE CLINICAL OUTCOMES

Sara Mustafa, Medical Research Centre, Te Huataki Waiora School of Health, University of Waikato, Hamilton, New Zealand

PP&B32

THE EFFECT OF PROBIOTIC SUPPLEMENTS ON METABOLIC PARAMETERS OF PEOPLE WITH TYPE 2 DIBETES IN GREECE —A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Eva Zikou, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Laiko General Hospital, 11527 Athens, Greece

PP&B33

MONITORING HEALTHCARE PATHWAY IN PAEDIATRIC PATIENTS WITH TYPE 1 DIABETES. PRELIMINARY RESULTS OF A REAL-WORLD POPULATION-BASED HISTORICAL COHORT STUDY IN A REGION OF CENTRAL ITALY

Alessandro Magnini, Centre for Epidemiology, Biostatistics and Medical Informatics (EBI), Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona

PP&B34

THE PROSPECTIVE ASSOCIATIONS OF EATING BEHAVIOR TYPES WITH GLYCEMIC CONTROL AND METABOLIC MEASURES IN PEOPLE WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT

Sanne Kremers, Epidemiology and Data Science, Amsterdam UMC; Amsterdam Public Health research institute, Amsterdam, the Netherlands

14:30 – 15:30

Oral Presentation, session 6
Treatment in Diabetes

Chair: Peter Harms  and Ghazal Fazli

4 presentations 15 minutes each (10 min. slides + 5 min. discussion)

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

OP21

GLUCOMETRICS AND DEVICE SATISFACTION IN ADULTS WITH TYPE 1 DIABETES USING DIFFERENT TREATMENT MODALITIES: A MULTICENTER REAL-WORLD OBSERVATIONAL STUDY

Andrea Faragalli, Centre for Epidemiology, Biostatistics and Medical Informatics (EBI), Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona

OP22

COMPARATIVE EFFECTIVENESS OF NEWER GLUCOSE-LOWERING DRUGS ON THE RISK OF MYOCARDIAL INFARCTION, STROKE, AND ALL-CAUSE MORTALITY IN THE ELDERLY: A TARGET TRIAL EMULATION BASED ON DANISH REGISTER DATA

Vanja Kosjerina, Steno Diabetes Center Copenhagen, Herlev, Denmark; Department of Endocrinology, Bispebjerg Hospital, Copenhagen, Denmark

OP23

DOES LIPID-LOWERING DRUGS REDUCE THE RISK OF DYING FROM DEMENTIA IN PERSONS WITH TYPE 2 DIABETES – A DANISH POPULATION-WIDE NESTED CASE-CONTROL STUDY

Susanne Graversen, Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark

OP24

THE EFFECTIVENESS OF TELEMEDICINE IN THE PREVENTION OF TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTERVENTIONS

Daniel Ibsen, MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom; Department of Public Health, Aarhus University, Aarhus, Denmark; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark; Department of Nutrition, Sports and Exercise, University of Copenhagen, Frederiksberg, Denmark

15:30 – 16:30

Poster Pitches & Boards, session 5
Other hot themes

Chair: Alessandro Magnini

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

PP&B35

SARS-CoV-2 OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES

German Tapia, Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway

PP&B36

INTAKE AND CIRCULATING LEVELS OF VITAMIN C, VITAMIN E, AND BETA-CAROTENE AND RISK OF TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND DOSE-RESPONSE META-ANALYSIS

Anna-Maria Lampousi, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

PP&B37

EXPOSURE TO ANTIBIOTICS AND THE RISK OF LADA

Jessica Edstorp, Institute of Environmental Medicine, Karolinska Institutet, Stockholm

PP&B38

OBESITY ON THE RISE: PREVALENCE OF OBESITY IN GREENLAND

Helene Nielsen, Steno Diabetes Center Greenland, Nuuk, Greenland; Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark

PP&B39

RECENT UPTAKE PATTERNS FOR ANTI-OBESITY DRUGS IN NORWAY

Paz Lopez-Doriga Ruiz, Norwegian Institute of Public Health, Oslo, Norway

PP&B40

METABOLIC SYNDROME IN PEOPLE LIVING WITH TYPE 1 DIABETES IN BELGIUM : A CROSS-SECTIONAL, REAL-LIFE OBSERVATIONAL STUDY

Astrid Lavens, Sciensano, Brussels, Belgium

PP&B41

A DYNAMIC RISK MODEL FOR JOINT MODELLING OF IMMUNE AND METABOLIC HEALTH AMONG PEOPLE LIVING WITH HIV AND DIABETES IN THE DC COHORT

Marinella Temprosa, Department of Biostatistics and Bioinformatics, George Washington University, Washington, USA

PP&B42

COELIAC DISEASE IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES IN MARCHE REGION: RESULTS FROM A POPULATION-BASED STUDY USING SECONDARY SOURCES

Alessandro Fontanarosa, Centre for Epidemiology, Biostatistics and Medical Informatics (EBI), Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona

PP&B43

FAMILY BURDEN OF AUTOIMMUNE DISEASES AND RISK OF TYPE 1 DIABETES

Ieva Strele, Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark; University of Latvia; Riga Stradins University, Riga, Latvia

16:30 – 17:00

Exercise & tea/coffee break
Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

17:00 – 18:00

Oral Presentation, session 7
Prediction and Diabetes & Cancer

Chair: Ieva Strele and Jonas Schaarup

4 presentations 15 minutes each (10 min. slides + 5 min. discussion)

Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

OP25

SMOKING, GAD65 AUTOIMMUNITY AND RISK OF ADULT-ONSET DIABETES IN THE EPIC-INTERACT CASE-COHORT STUDY

Emmy Keysendal, Karolinska Institutet, Stockholm, Sweden

OP26

OPTIMAL TIMING OF ECG SCREENING? – A PREDICTION MODEL FOR THE DETECTION OF ECG ABNORMALITIES IN PATIENTS WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT

Sharon Remmelzwaal, Departments of General Practice and Epidemiology and Data Science, Amsterdam UMC; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands

OP27

THE IMPACT OF TYPE 2 DIABETES ON ADHERENCE TO COLONOSCOPY FOLLOWING A POSITIVE TEST OF HIDDEN BLOOD IN THE DANISH COLORECTAL SCREENING PROGRAM

Tinne Laurberg, Steno Diabetes Center Aarhus, Aarhus University Hospital; Department of pathology, Aarhus University Hospital, Aarhus N, Denmark

OP28

THE IMPACT OF TYPE 2 DIABETES ON MELANOMA STAGE AT DIAGNOSIS: DIFFERENT TUMOR AGGRESSIVENESS PATTERNS AND SEX SPECIFIC ASSOCIATIONS

Jens Ejrnæs Tønder, Steno Diabetes Center Aarhus, Aarhus, Denmark

18:00 – 18:15

Closing remarks
Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom

19:00 – 24:00

Gala dinner and party with music
Paolo Vineis
School of Public Health, Imperial College, Medical Research Council (MRC) Centre for Environment and Health, London, United Kingdom